Exchange: NASDAQ·Updated 08:28 AM EDT
BIAF logo

BIAF BioAffinity Technologies Inc

$4.82
$0.05
(1.03%)
Pre-Market
Prev Close $4.87
Reported EarningsAug 7
Mkt Cap$2.88M
Vol1,393.00

About BIAF

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
40

Bearish Sentiment

How do you feel about BIAF?

Advertisement|Remove ads.